GILD

Gilead Sciences
D

GILD

Arincen87/100B
166.870
USD
-0.73
(-0.44%)
Pre Open·168.040USD+1.170(+0.70%)
Last updated: · Delayed 15 min

Gilead Sciences stock buybacks 1990–2026

Gilead Sciences spent 370.00M USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, down 14.9% on the same quarter a year before. Gilead Sciences spent 1.37B USD buying back its shares over the last twelve months, down 32.7% on the twelve months before. In fiscal year 2025 it spent 1.92B USD, up 67.1% on the year before.

Last updated 9 Nov 2026 · Next report 9 Feb 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 20261.37B-32.71%4.10B13.78B
FY202531 Dec 20251.92B+67.13%4.00B9.46B
FY202431 Dec 20241.15B+15.00%3.92B10.31B
FY202331 Dec 20231.00B-28.37%3.81B7.42B
FY202231 Dec 20221.40B+155.68%3.71B8.34B
FY202131 Dec 2021546.00M-65.51%3.61B10.81B
FY202031 Dec 20201.58B-9.49%3.45B7.52B
FY201931 Dec 20191.75B-39.69%3.22B8.32B
FY201831 Dec 20182.90B+203.98%2.97B7.48B
FY201731 Dec 2017954.00M-91.33%2.73B11.31B
FY201631 Dec 201611.00B+9.99%2.46B16.30B
FY201531 Dec 201510.00B+86.99%1.87B20.50B
FY201431 Dec 20145.35B+819.07%0.0012.26B
FY201331 Dec 2013582.00M-12.74%0.002.92B
FY201231 Dec 2012667.00M-72.01%0.002.80B
FY201131 Dec 20112.38B-40.76%0.003.51B
FY201031 Dec 20104.02B+302.87%0.002.77B
FY200931 Dec 2009998.50M-49.30%0.002.85B
FY200831 Dec 20081.97B+303.98%0.002.03B
FY200731 Dec 2007487.54M-10.53%0.001.69B
FY200631 Dec 2006544.94M—0.001.11B
FY200531 Dec 20050.00—0.00657.69M
FY200431 Dec 20040.00—0.00456.60M
FY200331 Dec 20030.00—0.00196.00M
FY200231 Dec 20020.00—0.0056.81M
FY200131 Dec 20010.00—0.00-153.31M
FY200031 Dec 20000.00—0.00-53.82M
FY199931 Dec 19990.00—0.00-75.10M
FY199831 Dec 19980.00—0.00-62.30M
FY199731 Dec 19970.00—0.00-68.30M
FY199631 Dec 19960.00—0.00-20.20M
FY199531 Dec 19950.00—0.00-23.60M
FY199431 Dec 19940.00—0.00-31.30M
FY199231 Dec 19920.00—0.00-13.30M
FY199131 Dec 19910.00—0.00-4.20M
FY199031 Dec 19900.00—0.00-2.70M

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Gilead Sciences's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.